India-Style Patent Laws Targeted In Trans-Pacific Trade Negotiations
This article was originally published in The Pink Sheet Daily
Draft intellectual property chapter of the Trans-Pacific Partnership includes a provision prohibiting signatories from denying patents solely because a product did not show enhanced efficacy over a known product.
You may also be interested in...
Trans-Pacific Partnership excludes patent linkage, evergreening provisions that industry had sought in addition to 12 years for biologics data exclusivity, which got knocked back to eight years.
As negotiations over Trans-Pacific Partnership Agreement near completion, generic drug advocates make all-out push to eliminate IP provisions, particularly one they say would create patent linkage for biologics.
The draft text highlights some key disagreements on intellectually property law questions between countries negotiating the comprehensive Trans-Pacific Partnership free trade agreement, including those related to method patents.